WallStreetZenWallStreetZen

NASDAQ: CDTX
Cidara Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CDTX

Based on 2 analysts offering 12 month price targets for Cidara Therapeutics Inc.
Min Forecast
$3.00+328.57%
Avg Forecast
$4.50+542.86%
Max Forecast
$6.00+757.14%

Should I buy or sell CDTX stock?

Based on 2 analysts offering ratings for Cidara Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDTX stock forecasts and price targets.

CDTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-07
lockedlocked$00.00+00.00%2023-09-22

1 of 1

Forecast return on equity

Is CDTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is CDTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CDTX revenue forecast

What is CDTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$27.9M-50.64%
Avg 2 year Forecast
$107.2M+89.54%
Avg 3 year Forecast
$132.5M+134.41%
CDTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDTX revenue growth forecast

How is CDTX forecast to perform vs Biotechnology companies and vs the US market?
Company
35.78%
Industry
52.23%
Market
10%
CDTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDTX$0.70$4.50+542.86%Buy
MNOV$1.28N/AN/A
APLM$0.70$17.00+2,332.05%Buy
IKNA$1.33$9.50+614.29%Buy
KRON$1.07$4.25+297.20%Strong Buy

Cidara Therapeutics Stock Forecast FAQ

Is Cidara Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDTX) stock is to Buy CDTX stock.

Out of 2 analysts, 0 (0%) are recommending CDTX as a Strong Buy, 2 (100%) are recommending CDTX as a Buy, 0 (0%) are recommending CDTX as a Hold, 0 (0%) are recommending CDTX as a Sell, and 0 (0%) are recommending CDTX as a Strong Sell.

If you're new to stock investing, here's how to buy Cidara Therapeutics stock.

What is CDTX's revenue growth forecast for 2024-2026?

(NASDAQ: CDTX) Cidara Therapeutics's forecast annual revenue growth rate of 35.78% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 52.23%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10%.

Cidara Therapeutics's revenue in 2024 is $56,541,000.On average, 1 Wall Street analysts forecast CDTX's revenue for 2024 to be $2,524,006,716, with the lowest CDTX revenue forecast at $2,524,006,716, and the highest CDTX revenue forecast at $2,524,006,716. On average, 1 Wall Street analysts forecast CDTX's revenue for 2025 to be $9,691,787,881, with the lowest CDTX revenue forecast at $9,691,787,881, and the highest CDTX revenue forecast at $9,691,787,881.

In 2026, CDTX is forecast to generate $11,986,092,804 in revenue, with the lowest revenue forecast at $11,986,092,804 and the highest revenue forecast at $11,986,092,804.

What is CDTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CDTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CDTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDTX price target, the average CDTX price target is $4.50, with the highest CDTX stock price forecast at $6.00 and the lowest CDTX stock price forecast at $3.00.

On average, Wall Street analysts predict that Cidara Therapeutics's share price could reach $4.50 by Dec 7, 2024. The average Cidara Therapeutics stock price prediction forecasts a potential upside of 542.86% from the current CDTX share price of $0.70.

What is CDTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CDTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.